FDA's Fast-Track Drug Voucher Faces Legal and Safety Scrutiny

The FDA's National Priority Voucher program aims to speed drug approvals, but critics warn it bypasses standard scientific and regulatory safeguards, raising concerns about who signs off on decisions and whether political pressure is affecting timelines amid staff upheaval and safety worries.